Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
18.83
-0.86 (-4.37%)
At close: Jun 12, 2026, 4:00 PM EDT
20.01
+1.18 (6.27%)
After-hours: Jun 12, 2026, 7:47 PM EDT
RGC Market Cap
RGC has a market cap or net worth of $9.33 billion as of June 12, 2026. Its market cap has decreased by -3.24% in one year.
Market Cap
9.33B
Enterprise Value
9.33B
1-Year Change
-3.24%
Ranking
Category
Stock Price
$18.83
Market Cap Chart
Since the IPO on July 16, 2021, RGC's market cap has increased from $120.10M to $9.33B, an increase of 7,668.34%. That is a compound annual growth rate of 142.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 9.33B | -10.15% |
| Dec 31, 2025 | 10.38B | 16,053.85% |
| Dec 31, 2024 | 64.28M | -52.95% |
| Dec 29, 2023 | 136.63M | -62.35% |
| Dec 29, 2022 | 362.93M | -12.12% |
| Dec 31, 2021 | 413.00M | 243.88% |
| Jul 16, 2021 | 120.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| United Therapeutics | 23.15B |
| Viatris | 18.99B |
| Neurocrine Biosciences | 16.36B |
| Elanco Animal Health | 12.01B |
| Dr. Reddy's Laboratories | 11.14B |
| Alkermes | 7.49B |
| Lantheus Holdings | 6.79B |
| Hims & Hers Health | 6.68B |